SIAV S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.46 EUR | -1.60% |
|
0.00% | -19.34% |
| Apr. 29 | Siav S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 03 | ITALY GROWTH WINNERS & LOSERS: Health Italia and Askoll EVA leading the way. | AN |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 28.43 | 27.3 | 22.38 | - | - |
| Enterprise Value (EV) 1 | 35.57 | 27.3 | 40.73 | 37.46 | 31.12 |
| P/E ratio | - | - | - | - | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 0.88 x | 0.82 x | 0.58 x | 0.5 x | 0.44 x |
| EV / Revenue | 1.1 x | 0.82 x | 1.05 x | 0.84 x | 0.62 x |
| EV / EBITDA | 6.1 x | 5.12 x | 5.26 x | 3.88 x | 2.61 x |
| EV / FCF | -8.53 x | - | 17.9 x | 6.94 x | 3.99 x |
| FCF Yield | -11.7% | - | 5.6% | 14.4% | 25.1% |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 9,170 | 8,952 | 8,952 | - | - |
| Reference price 2 | 3.100 | 3.050 | 2.500 | 2.500 | 2.500 |
| Announcement Date | 3/27/23 | 4/29/24 | - | - | - |
1EUR in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 32.39 | 33.15 | 38.68 | 44.48 | 50.5 |
| EBITDA 1 | - | 5.835 | 5.336 | 7.75 | 9.655 | 11.91 |
| EBIT 1 | - | 1.76 | 0.907 | 3.05 | 4.805 | 7.01 |
| Operating Margin | - | 5.43% | 2.74% | 7.88% | 10.8% | 13.88% |
| Earnings before Tax (EBT) | 1.28 | - | - | - | - | - |
| Net income | 1.144 | - | - | - | - | - |
| Net margin | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -4.168 | - | 2.28 | 5.4 | 7.8 |
| FCF margin | - | -12.87% | - | 5.89% | 12.14% | 15.45% |
| FCF Conversion (EBITDA) | - | - | - | 29.42% | 55.93% | 65.49% |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/2/22 | 3/27/23 | 4/29/24 | - | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 7.14 | - | 18.4 | 15.1 | 8.74 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 1.224 x | - | 2.368 x | 1.561 x | 0.7338 x |
| Free Cash Flow 1 | - | -4.17 | - | 2.28 | 5.4 | 7.8 |
| ROE (net income / shareholders' equity) | - | 14.5% | - | 14.5% | 19.2% | 24% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 7.09 | - | 5 | 4.47 | 4.14 |
| Capex / Sales | - | 21.9% | - | 12.92% | 10.04% | 8.19% |
| Announcement Date | 8/2/22 | 3/27/23 | 4/29/24 | - | - | - |
1EUR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.5
EUR
Average target price
6.845
EUR
Spread / Average Target
+173.80%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.34% | 24.05M | |
| +9.05% | 3,051B | |
| +6.72% | 83.97B | |
| +4.10% | 76.9B | |
| -13.69% | 54B | |
| +22.54% | 48.01B | |
| -24.70% | 46.47B | |
| +22.10% | 42.04B | |
| +63.54% | 38.34B | |
| -34.03% | 24.97B |
- Stock Market
- Equities
- SIAV Stock
- Financials Siav S.p.A.